These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 25084510)

  • 1. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
    Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
    Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
    Kanao H; Aoki Y; Omi M; Nomura H; Tanigawa T; Okamoto S; Chang EJ; Kurita T; Netsu S; Matoda M; Omatsu K; Matsuo K
    Gynecol Oncol; 2021 Apr; 161(1):34-38. PubMed ID: 33423805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
    Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
    J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
    Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
    Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (Laterally) extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy.
    Höckel M; Horn LC; Einenkel J
    Gynecol Oncol; 2012 Nov; 127(2):297-302. PubMed ID: 22864112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
    Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
    Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
    Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
    Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).
    Arians N; Foerster R; Rom J; Uhl M; Roeder F; Debus J; Lindel K
    Radiat Oncol; 2016 Mar; 11():44. PubMed ID: 26988089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic laterally extended endopelvic resection (LEER) for cervical carcinoma recurring at the pelvic sidewall after concurrent chemoradiotherapy: Our experience in three cases.
    Kanao H; Aoki Y; Hisa T; Takeshima N
    Gynecol Oncol; 2018 May; 149(2):428-429. PubMed ID: 29510867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer?
    Baiocchi G; Guimaraes GC; Faloppa CC; Kumagai LY; Oliveira RA; Begnami MD; Soares FA; Lopes A
    Ann Surg Oncol; 2013 May; 20(5):1694-700. PubMed ID: 23212765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
    Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma.
    Paly JJ; Hallemeier CL; Biggs PJ; Niemierko A; Roeder F; Martínez-Monge R; Whitson J; Calvo FA; Fastner G; Sedlmayer F; Wong WW; Ellis RJ; Haddock MG; Choo R; Shipley WU; Zietman AL; Efstathiou JA
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):618-23. PubMed ID: 24411190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall.
    Höckel M
    Gynecol Oncol; 2003 Nov; 91(2):369-77. PubMed ID: 14599868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies.
    Tran PT; Su Z; Hara W; Husain A; Teng N; Kapp DS
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):504-11. PubMed ID: 17560736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
    Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of recurrent cervical cancer: a review of the literature.
    Peiretti M; Zapardiel I; Zanagnolo V; Landoni F; Morrow CP; Maggioni A
    Surg Oncol; 2012 Jun; 21(2):e59-66. PubMed ID: 22244884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laterally extended endopelvic resection (LEER)--principles and practice.
    Höckel M
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S13-7. PubMed ID: 18723213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.